Japan Opioids Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Opioids market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Opioids market. Detailed analysis of key players, along with key growth strategies adopted by Opioids industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Egalet Corporation

    • Sun Pharmaceutical Industries Limited.

    • Teva pharmaceuticals

    • Endo Pharmaceuticals

    • AbbVie

    • West-Ward Pharmaceuticals Corporation

    • Sanofi

    • Purdue Pharma

    • Hospira

    • Janssen Pharmaceuticals, Inc.

    • Allergan

    • Orexo Pharmaceuticals

    • Pfizer


    By Type:

    • Hydrocodone

    • Codeine

    • Oxycodone

    • Morphine

    • Others


    By End-User:

    • Neuropathic Pain Treatment

    • Orthopedic Pain Treatment

    • Other Pain Treatment


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioids Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Opioids Market Size and Growth Rate of Hydrocodone from 2014 to 2026

      • 1.3.2 Japan Opioids Market Size and Growth Rate of Codeine from 2014 to 2026

      • 1.3.3 Japan Opioids Market Size and Growth Rate of Oxycodone from 2014 to 2026

      • 1.3.4 Japan Opioids Market Size and Growth Rate of Morphine from 2014 to 2026

      • 1.3.5 Japan Opioids Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Opioids Market Size and Growth Rate of Neuropathic Pain Treatment from 2014 to 2026

      • 1.4.2 Japan Opioids Market Size and Growth Rate of Orthopedic Pain Treatment from 2014 to 2026

      • 1.4.3 Japan Opioids Market Size and Growth Rate of Other Pain Treatment from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Opioids Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Opioids Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioids by Major Types

      • 3.4.1 Market Size and Growth Rate of Hydrocodone

      • 3.4.2 Market Size and Growth Rate of Codeine

      • 3.4.3 Market Size and Growth Rate of Oxycodone

      • 3.4.4 Market Size and Growth Rate of Morphine

      • 3.4.5 Market Size and Growth Rate of Others


    4 Segmentation of Opioids Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioids by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioids in Neuropathic Pain Treatment

      • 4.4.2 Market Size and Growth Rate of Opioids in Orthopedic Pain Treatment

      • 4.4.3 Market Size and Growth Rate of Opioids in Other Pain Treatment


    5 Market Analysis by Regions

    • 5.1 Japan Opioids Production Analysis by Regions

    • 5.2 Japan Opioids Consumption Analysis by Regions


    6 Hokkaido Opioids Landscape Analysis

    • 6.1 Hokkaido Opioids Landscape Analysis by Major Types

    • 6.2 Hokkaido Opioids Landscape Analysis by Major End-Users


    7 Tohoku Opioids Landscape Analysis

    • 7.1 Tohoku Opioids Landscape Analysis by Major Types

    • 7.2 Tohoku Opioids Landscape Analysis by Major End-Users


    8 Kanto Opioids Landscape Analysis

    • 8.1 Kanto Opioids Landscape Analysis by Major Types

    • 8.2 Kanto Opioids Landscape Analysis by Major End-Users


    9 Chubu Opioids Landscape Analysis

    • 9.1 Chubu Opioids Landscape Analysis by Major Types

    • 9.2 Chubu Opioids Landscape Analysis by Major End-Users


    10 Kinki Opioids Landscape Analysis

    • 10.1 Kinki Opioids Landscape Analysis by Major Types

    • 10.2 Kinki Opioids Landscape Analysis by Major End-Users


    11 Chugoku Opioids Landscape Analysis

    • 11.1 Chugoku Opioids Landscape Analysis by Major Types

    • 11.2 Chugoku Opioids Landscape Analysis by Major End-Users


    12 Shikoku Opioids Landscape Analysis

    • 12.1 Shikoku Opioids Landscape Analysis by Major Types

    • 12.2 Shikoku Opioids Landscape Analysis by Major End-Users


    13 Kyushu Opioids Landscape Analysis

    • 13.1 Kyushu Opioids Landscape Analysis by Major Types

    • 13.2 Kyushu Opioids Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Egalet Corporation

      • 14.1.1 Egalet Corporation Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Sun Pharmaceutical Industries Limited.

      • 14.2.1 Sun Pharmaceutical Industries Limited. Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Teva pharmaceuticals

      • 14.3.1 Teva pharmaceuticals Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Endo Pharmaceuticals

      • 14.4.1 Endo Pharmaceuticals Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 AbbVie

      • 14.5.1 AbbVie Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 West-Ward Pharmaceuticals Corporation

      • 14.6.1 West-Ward Pharmaceuticals Corporation Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Sanofi

      • 14.7.1 Sanofi Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Purdue Pharma

      • 14.8.1 Purdue Pharma Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Hospira

      • 14.9.1 Hospira Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Janssen Pharmaceuticals, Inc.

      • 14.10.1 Janssen Pharmaceuticals, Inc. Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Allergan

      • 14.11.1 Allergan Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Orexo Pharmaceuticals

      • 14.12.1 Orexo Pharmaceuticals Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Pfizer

      • 14.13.1 Pfizer Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 134 Figures and 179 Tables)

     

    • Figure Japan Opioids Market Size and Growth Rate of Hydrocodone from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Codeine from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Oxycodone from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Morphine from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Opioids Market Size and Growth Rate of Neuropathic Pain Treatment from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Orthopedic Pain Treatment from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Other Pain Treatment from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioids Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioids

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioids by Different Types from 2014 to 2026

    • Table Consumption Share of Opioids by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Hydrocodone

    • Figure Market Size and Growth Rate of Codeine

    • Figure Market Size and Growth Rate of Oxycodone

    • Figure Market Size and Growth Rate of Morphine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioids by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioids by Different End-Users from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Neuropathic Pain Treatment from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Orthopedic Pain Treatment from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Other Pain Treatment from 2014 to 2026

    • Table Japan Opioids Production by Regions

    • Table Japan Opioids Production Share by Regions

    • Figure Japan Opioids Production Share by Regions in 2014

    • Figure Japan Opioids Production Share by Regions in 2018

    • Figure Japan Opioids Production Share by Regions in 2026

    • Table Japan Opioids Consumption by Regions

    • Table Japan Opioids Consumption Share by Regions

    • Figure Japan Opioids Consumption Share by Regions in 2014

    • Figure Japan Opioids Consumption Share by Regions in 2018

    • Figure Japan Opioids Consumption Share by Regions in 2026

    • Table Hokkaido Opioids Consumption by Types from 2014 to 2026

    • Table Hokkaido Opioids Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Opioids Consumption Share by Types in 2014

    • Figure Hokkaido Opioids Consumption Share by Types in 2018

    • Figure Hokkaido Opioids Consumption Share by Types in 2026

    • Table Hokkaido Opioids Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Opioids Consumption Share by End-Users in 2014

    • Figure Hokkaido Opioids Consumption Share by End-Users in 2018

    • Figure Hokkaido Opioids Consumption Share by End-Users in 2026

    • Table Tohoku Opioids Consumption by Types from 2014 to 2026

    • Table Tohoku Opioids Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Opioids Consumption Share by Types in 2014

    • Figure Tohoku Opioids Consumption Share by Types in 2018

    • Figure Tohoku Opioids Consumption Share by Types in 2026

    • Table Tohoku Opioids Consumption by End-Users from 2014 to 2026

    • Table Tohoku Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Opioids Consumption Share by End-Users in 2014

    • Figure Tohoku Opioids Consumption Share by End-Users in 2018

    • Figure Tohoku Opioids Consumption Share by End-Users in 2026

    • Table Kanto Opioids Consumption by Types from 2014 to 2026

    • Table Kanto Opioids Consumption Share by Types from 2014 to 2026

    • Figure Kanto Opioids Consumption Share by Types in 2014

    • Figure Kanto Opioids Consumption Share by Types in 2018

    • Figure Kanto Opioids Consumption Share by Types in 2026

    • Table Kanto Opioids Consumption by End-Users from 2014 to 2026

    • Table Kanto Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Opioids Consumption Share by End-Users in 2014

    • Figure Kanto Opioids Consumption Share by End-Users in 2018

    • Figure Kanto Opioids Consumption Share by End-Users in 2026

    • Table Chubu Opioids Consumption by Types from 2014 to 2026

    • Table Chubu Opioids Consumption Share by Types from 2014 to 2026

    • Figure Chubu Opioids Consumption Share by Types in 2014

    • Figure Chubu Opioids Consumption Share by Types in 2018

    • Figure Chubu Opioids Consumption Share by Types in 2026

    • Table Chubu Opioids Consumption by End-Users from 2014 to 2026

    • Table Chubu Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Opioids Consumption Share by End-Users in 2014

    • Figure Chubu Opioids Consumption Share by End-Users in 2018

    • Figure Chubu Opioids Consumption Share by End-Users in 2026

    • Table Kinki Opioids Consumption by Types from 2014 to 2026

    • Table Kinki Opioids Consumption Share by Types from 2014 to 2026

    • Figure Kinki Opioids Consumption Share by Types in 2014

    • Figure Kinki Opioids Consumption Share by Types in 2018

    • Figure Kinki Opioids Consumption Share by Types in 2026

    • Table Kinki Opioids Consumption by End-Users from 2014 to 2026

    • Table Kinki Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Opioids Consumption Share by End-Users in 2014

    • Figure Kinki Opioids Consumption Share by End-Users in 2018

    • Figure Kinki Opioids Consumption Share by End-Users in 2026

    • Table Chugoku Opioids Consumption by Types from 2014 to 2026

    • Table Chugoku Opioids Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Opioids Consumption Share by Types in 2014

    • Figure Chugoku Opioids Consumption Share by Types in 2018

    • Figure Chugoku Opioids Consumption Share by Types in 2026

    • Table Chugoku Opioids Consumption by End-Users from 2014 to 2026

    • Table Chugoku Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Opioids Consumption Share by End-Users in 2014

    • Figure Chugoku Opioids Consumption Share by End-Users in 2018

    • Figure Chugoku Opioids Consumption Share by End-Users in 2026

    • Table Shikoku Opioids Consumption by Types from 2014 to 2026

    • Table Shikoku Opioids Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Opioids Consumption Share by Types in 2014

    • Figure Shikoku Opioids Consumption Share by Types in 2018

    • Figure Shikoku Opioids Consumption Share by Types in 2026

    • Table Shikoku Opioids Consumption by End-Users from 2014 to 2026

    • Table Shikoku Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Opioids Consumption Share by End-Users in 2014

    • Figure Shikoku Opioids Consumption Share by End-Users in 2018

    • Figure Shikoku Opioids Consumption Share by End-Users in 2026

    • Table Kyushu Opioids Consumption by Types from 2014 to 2026

    • Table Kyushu Opioids Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Opioids Consumption Share by Types in 2014

    • Figure Kyushu Opioids Consumption Share by Types in 2018

    • Figure Kyushu Opioids Consumption Share by Types in 2026

    • Table Kyushu Opioids Consumption by End-Users from 2014 to 2026

    • Table Kyushu Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Opioids Consumption Share by End-Users in 2014

    • Figure Kyushu Opioids Consumption Share by End-Users in 2018

    • Figure Kyushu Opioids Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Egalet Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Egalet Corporation

    • Figure Sales and Growth Rate Analysis of Egalet Corporation

    • Figure Revenue and Market Share Analysis of Egalet Corporation

    • Table Product and Service Introduction of Egalet Corporation

    • Table Company Profile and Development Status of Sun Pharmaceutical Industries Limited.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries Limited.

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries Limited.

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries Limited.

    • Table Product and Service Introduction of Sun Pharmaceutical Industries Limited.

    • Table Company Profile and Development Status of Teva pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Teva pharmaceuticals

    • Figure Revenue and Market Share Analysis of Teva pharmaceuticals

    • Table Product and Service Introduction of Teva pharmaceuticals

    • Table Company Profile and Development Status of Endo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Endo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Endo Pharmaceuticals

    • Table Product and Service Introduction of Endo Pharmaceuticals

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of West-Ward Pharmaceuticals Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of West-Ward Pharmaceuticals Corporation

    • Figure Sales and Growth Rate Analysis of West-Ward Pharmaceuticals Corporation

    • Figure Revenue and Market Share Analysis of West-Ward Pharmaceuticals Corporation

    • Table Product and Service Introduction of West-Ward Pharmaceuticals Corporation

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of Janssen Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Janssen Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Orexo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Orexo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Orexo Pharmaceuticals

    • Table Product and Service Introduction of Orexo Pharmaceuticals

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.